Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Zhi-Xin Xu"'
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
The surge in global energy demand mandates a significant expansion of electric power substations. Nevertheless, the ecological consequences of electric power substation operation, particularly concerning the electromagnetic field, on soil microbial c
Externí odkaz:
https://doaj.org/article/a155ed8fe4704a8aadc142adfe7ccb00
Publikováno v:
BMC Anesthesiology, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background The Bispectral Index (BIS) and the Patient State Index (PSI) are commonly used measures to assess intraoperative sedation depth. However, model differences lead to different results, which in turn interferes with clinicians’ jud
Externí odkaz:
https://doaj.org/article/41ee4d48883442e7952b79a707bc2027
Publikováno v:
BMC Anesthesiology, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Remimazolam tosilate (RT) is a newly listed benzodiazepine for sedation and anesthesia featuring quick onset of effects, short maintenance and recovery times, which is currently under research. This trial was conducted to determin
Externí odkaz:
https://doaj.org/article/3cf6d38d0cc34b47ae5160a0909c8293
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 6, Iss 1, Pp 1-5 (2020)
Primary aldosteronism (PA) is a common form of endocrine hypertension. The diagnostic process of PA includes a screening test, confirmatory test, and subtype classification. In this review, we have summarized the latest advances in the diagnosis of P
Externí odkaz:
https://doaj.org/article/f08886a604b5439595a5690e78ddc994
Autor:
Xiao-hong Wang, Yu-lei Deng, Qiao-yu Li, Zhi-xin Xu, Teng-fei Ma, Xing Yang, Duo Dong, Dong-dong Zhu, Xiao-hong Yang
Publikováno v:
China Foundry; May2024, Vol. 21 Issue 3, p265-275, 11p
Autor:
Wilfried Ernst Erich Eberhardt, Jan H.M. Schellens, Valerie Meresse Naegelen, Steve Blotner, Eliezer Shochat, Jean J.L. Tessier, Ruediger Rueger, Zhi-Xin Xu, Vanesa Lopez-Valverde, Avinash Gupta, Max E. Scheulen, Veronique Dieras, Françoise Kraeber-Bodéré, Patricia Tresca, Mark R. Middleton, Suzanne Leijen
PDF file, 1001K, Methods; Supplementary Table 1 - Temporary dose interruptions due to adverse events; Supplementary Table 2 - Changes in biomarker levels between baseline and Day 15; Supplementary Figure 1: Schematic showing dosing cohorts, DLTs and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d7be86e7d7ff6abbb2f08c3c8e17ccc
https://doi.org/10.1158/1078-0432.22452476.v1
https://doi.org/10.1158/1078-0432.22452476.v1
Autor:
Jean-Charles Soria, Valerie Meresse Naegelen, Steve Blotner, Eliezer Shochat, Jean J. L. Tessier, Ruediger Rueger, Zhi-Xin Xu, Ernesto Guarin, Emilie Routier, Federico Rojo, Françoise Kraeber-Bodéré, Saoirse Dolly, Rastilav Bahleda, Joan Albanell, Udai Banerji, Maria Martinez-Garcia
PDF file, 130K.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::006b8947be1db4b35cb0c1be9eb3d2ac
https://doi.org/10.1158/1078-0432.22451105.v1
https://doi.org/10.1158/1078-0432.22451105.v1
Autor:
Jean-Charles Soria, Valerie Meresse Naegelen, Steve Blotner, Eliezer Shochat, Jean J. L. Tessier, Ruediger Rueger, Zhi-Xin Xu, Ernesto Guarin, Emilie Routier, Federico Rojo, Françoise Kraeber-Bodéré, Saoirse Dolly, Rastilav Bahleda, Joan Albanell, Udai Banerji, Maria Martinez-Garcia
Purpose: This phase I study assessed the maximum tolerated dose (MTD), dose-limiting toxicities (DLT), safety, pharmacokinetics, pharmacodynamics, and clinical activity of the first-in-class dual MEK/RAF inhibitor, RO5126766.Experimental Design: Init
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbca345e19eeb5455a74ad1913cfe943
https://doi.org/10.1158/1078-0432.c.6522101
https://doi.org/10.1158/1078-0432.c.6522101
Autor:
Jean-Charles Soria, Valerie Meresse Naegelen, Steve Blotner, Eliezer Shochat, Jean J. L. Tessier, Ruediger Rueger, Zhi-Xin Xu, Ernesto Guarin, Emilie Routier, Federico Rojo, Françoise Kraeber-Bodéré, Saoirse Dolly, Rastilav Bahleda, Joan Albanell, Udai Banerji, Maria Martinez-Garcia
PDF file, 18K, Schematic showing cohort doses evaluated, dose-limiting-toxicities observed and maximum-tolerated-doses per dosing regimen.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b59472046794d1c2b3578f6cc4e14ad1
https://doi.org/10.1158/1078-0432.22451108.v1
https://doi.org/10.1158/1078-0432.22451108.v1
Autor:
Jean-Charles Soria, Valerie Meresse Naegelen, Steve Blotner, Eliezer Shochat, Jean J. L. Tessier, Ruediger Rueger, Zhi-Xin Xu, Ernesto Guarin, Emilie Routier, Federico Rojo, Françoise Kraeber-Bodéré, Saoirse Dolly, Rastilav Bahleda, Joan Albanell, Udai Banerji, Maria Martinez-Garcia
PDF file, 9K, Summary of pharmacokinetics of RO4987655 in patients following oral administration.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::088e1989b219d8b25cb6ff3d615e9d0d
https://doi.org/10.1158/1078-0432.22451102.v1
https://doi.org/10.1158/1078-0432.22451102.v1